Inhibition of inflammatory mediators contributes to the anti-inflammatory activity of KYKZL-1 via MAPK and NF-κB pathway

MLA

Yi-Fang Du, et al. “Inhibition of Inflammatory Mediators Contributes to the Anti-Inflammatory Activity of KYKZL-1 via MAPK and NF-ΚB Pathway.” Toxicology and Applied Pharmacology, vol. 272, no. 1, July 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....50814d6e7429a9c024b9b2005e76494b&authtype=sso&custid=ns315887.

APA

Yi-Fang Du, Ting Sun, Guang-Lin Xu, Shi-Cui Chen, Jie Cai, Lin Huan, Guizhen Ao, Ting Qiu, Jing Cheng, Shao-Hua Wei, Hao Wu, & Zhu-Nan Gong. (2012). Inhibition of inflammatory mediators contributes to the anti-inflammatory activity of KYKZL-1 via MAPK and NF-κB pathway. Toxicology and Applied Pharmacology, 272(1).

Chicago

Yi-Fang Du, Ting Sun, Guang-Lin Xu, Shi-Cui Chen, Jie Cai, Lin Huan, Guizhen Ao, et al. 2012. “Inhibition of Inflammatory Mediators Contributes to the Anti-Inflammatory Activity of KYKZL-1 via MAPK and NF-ΚB Pathway.” Toxicology and Applied Pharmacology 272 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....50814d6e7429a9c024b9b2005e76494b&authtype=sso&custid=ns315887.